VE ZKRATCE Rosacea: kožní nebo systémové onemocnění? | E31 / Vnitř Lék. 2023;69(6):E29-E31 / VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz LITERATURA 1. Gether L, Overgaard LK, Egeberg A, et al. Incidence and prevalence of rosacea: a systematic review and meta‑analysis. Br J Dermatol. 2018;179(2):282-289. 2. Morss‑Walton P, McGee JS. Rosacea, not just skin deep: Understanding the systemic disease burden. Clin Dermatol. 2021;39(4):695-700. 3. Tsai TY, Chiang YY, Huang YC. Cardiovascular R isk and Comorbidities in Patients with Rosacea: A Systematic Review and Meta‑analysis. Acta Derm Venereol. 2020;100(17):adv00300. 4. Zhang J, Yan Y, Jiang P, et al. Association between rosacea and cardiovascular disease: A systematic review and meta‑analysis. J Cosmet Dermatol. 2021;20(9):2715-2722. 5. Li Y, Guo L, Hao D, et al. Association between Rosacea and Cardiovascular Diseases and Related Risk Factors: A Systematic Review and Meta‑Analysis. Biomed Res Int. 2020;2020:7015249. doi: 10.1155/2020 6. Choi D, Choi S, Choi S, et al. Association of Rosacea With Cardiovascular Disease: A Retrospective Cohort Study. J Am Heart Assoc. 2021;10(19):e020671. 7. Dosal JR, Rodriguez GL, Pezon CF, et al. Effect of tetracyclines on the development of vascular disease in veterans with acne or rosacea: A retrospective cohort study. J. Investig. Dermatol. 2014;134:2267–2269. 8. Woo YR, Kim HS, Lee SH, et al. Systemic Comorbidities in Korean Patients with Rosacea: Results from a Multi‑Institutional Case‑Control Study. J. Clin. Med. 2020; 9(10):3336. 9. Wang FY, Chi CC. Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut‑Skin Axis of Rosacea. Adv Ther. 2021;38(3):1415-1424. 10. Egeberg A, Weinstock LB, Thyssen EP, et al. Rosacea and gastrointestinal disorders: a population‑based cohort study. Br J Dermatol. 2017;176(1):100-106. 11. Yi JZ, Lukac D, Pagani K, et al. Rosacea and upper gastrointestinal disorders: a case ‑control study from a large, urban academic centre. J Eur Acad Dermatol Venereol, 2022;36(3):e227-e229. 12. Egeberg A, Hansen PR, Gislason GH, et al Exploring the Association Between Rosacea and Parkinson Disease: A Danish Nationwide Cohort Study. JAMA Neurol. 2016;73(5):529-34. 13. Mathieu RJ, Guido N, Ibler E et al. Rosacea and subsequent diagnosis for Parkinson’s disease: a large, urban, single center, US patient population retrospective study. J Eur Acad Dermatol Venereol. 2018; 32(4):e141-e144. 14. Scharschmidt TC, Yost JM, Truong SV et al. Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment. Arch Dermatol. 2011;147(1): 123-6. 15. Li M, Tao M, Zhang Y, et al. Neurogenic rosacea could be a small fiber neuropathy. Front Pain Res (Lausanne). 2023;4:1122134. 16. Heisig M, Reich A. Psychosocial aspects of rosacea with a focus on anxiety and depression. Clin Cosmet Investig Dermatol. 2018;11:103-107. 17. Wienholtz NKF, Christensen CE, Zhang DG et al. Clinical characteristics of combined rosacea and migraine. Front Med (Lausanne). 2022;9:1026447. 18. Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with rosacea have increased risk of dementia. Ann Neurol. 2016;79(6):921-8. 19. Chang TH, Ho HJ, Chang YT, et al. Is rosacea a risk factor for cancer: A population‑based cohort study in Taiwan. Dermatol Sin 2020;38:15-21 20. Egeberg A, Hansen PR, Gislason GH, et al. Clustering of autoimmune diseases in patients with rosacea. J Am Acad Dermatol. 2016;74(4):667-72.e1. 21. Akin Belli A, Alatas ET, Kara Polat A, et al. Assessment of thyroid disorders in patients with rosacea: a large case‑control study. An Bras Dermatol. 2021;96(5):539-543.
RkJQdWJsaXNoZXIy NDA4Mjc=